Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LENSARLNSR +3.33%61 Days Inventory is 325.74 as of Jun. 2026, which is 51% above its 10-year median of 215.97. GuruFocus rates LNSR with a GF Score™ of 61/100 and a GF Value™ of $4.88 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 786 Medical Devices & Instruments companies, LENSAR ranks worse than 71.63% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). LENSAR's Average Total Inventories for the
three
months ended in Jun. 2026 was $23.99 Mil. LENSAR's Cost of Goods Sold for the
three
months ended in Jun. 2026 was $6.72 Mil.
Hence, LENSAR's Days Inventory for the
three
months ended in Jun. 2026 was 325.74.
The historical rank and industry rank for LENSAR's Days Inventory or its related term are showing as below:
LNSR'
s Days Inventory Range Over the Past 10 Years
Min: 170.15 Med: 215.97 Max: 319.37
Current: 256.35
During the past 7 years, LENSAR's highest Days Inventory was 319.37. The lowest was 170.15. And the median was 215.97.
LNSR's Days Inventory is ranked worse than 71.63% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 176.445
vs LNSR: 256.35
LENSAR's Days Inventory
increased
from Jun. 2025 (228.20) to Jun. 2026 (325.74).
It might indicate that LENSAR's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
LENSAR's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.28.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
LENSAR's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 1.45.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
LENSAR's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
LENSAR's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
LENSAR Days Inventory Related Terms
LENSAR Days Inventory Historical Data
* Premium members only.
The historical data trend for LENSAR's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, LENSAR's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LENSAR Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LENSAR's Days Inventory distribution charts can be found below:
* The bar in red indicates where LENSAR's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LENSAR (LNSR) has a Days Inventory of 325.74 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on LENSAR and its competitors. This is 51% above median its historical median of 215.97. Over the past decade, LENSAR's Days Inventory has ranged from 170.15 to 319.37. According to the industry distribution chart, LENSAR ranks #563 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 71.6%.
Is LENSAR's Days Inventory too high?
LENSAR's current Days Inventory of 325.74 is 51% above median its 10-year median of 215.97. Over the past 10 years, this metric has ranged from a low of 170.15 to a high of 319.37. The Medical Devices & Instruments industry median Days Inventory is 176.45. LENSAR's value of 325.74 is 84.6% above this industry median. Based on the distribution chart, LENSAR ranks #563 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, LENSAR has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LENSAR's Days Inventory compare to OM and NNOX?
According to the Medical Devices & Instruments industry distribution chart, LENSAR ranks #563 out of 786 companies for Days Inventory. This places LENSAR in the lower half of its industry. The industry median Days Inventory is 176.45. LENSAR's value of 325.74 is 84.6% above this benchmark. Historically, LENSAR's own Days Inventory has ranged from 170.15 to 319.37 over the past decade. While the company's 10-year median is 215.97 vs. the industry median of 176.45, LENSAR has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 176.45, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LENSAR's current Days Inventory of 325.74 is 84.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on LENSAR and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 176.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LENSAR's current Days Inventory is 325.74, which is 51% above median its own 10-year median of 215.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LENSAR stock overvalued right now?
Based on GuruFocus' analysis, LENSAR (LNSR) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.88, compared to a current price of $8.68 — trading 77.9% above its estimated fair value. The current Days Inventory is 325.74, which is 51% above median its 10-year median of 215.97 and 84.6% above the Medical Devices & Instruments industry median of 176.45. LENSAR's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For LENSAR (LNSR), the current Days Inventory is 325.74 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LENSAR (LNSR) Overvalued in 2026?
Based on GuruFocus' analysis, LENSAR stock appears to be overvalued.
The current stock price of $8.68 is trading 77.9% above its estimated GF Value™ of $4.88.
GuruFocus considers LENSAR to be Significantly Overvalued.
Key valuation signals for LNSR:
Days Inventory: 325.74 (51% above median its 10-year median of 215.97)
GF Value™: $4.88 vs. price of $8.68 (77.9% above fair value)
Industry Position: 84.6% above the Medical Devices & Instruments median (#563 of 786)
No single metric tells the full story. See the LNSR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
61GF Score
Get the complete analysis for LNSR
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LNSR has been successfully added to your 
